Clinical Trial Update: Combined Effects of Bioactive Compounds in Lipid Profile [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating the combined effects of bioactive compounds on lipid levels in individuals with hyperlipidemia and elevated triglycerides.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia
• Hypertriglyceridemia

Snippet

Sponsor: Rottapharm Spain | Conditions: Hyperlipidemia, Low-density-lipoprotein-type | Phase 2, Phase 3 | Status: COMPLETED